相关实验视频
Updated: May 28, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
在希斯脱乙酶 (HDAC) 抑制剂中探索替代结合组揭示了DS-103作为一种具有化学敏感性质的基于乙基的强大的HDAC抑制剂
Daniel Stopper1, Lukas Biermann2, Paris R Watson3
1Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.
Journal of medicinal chemistry
|February 13, 2025
概括
一种新的基于peptoid的化合物,DS-103,有效地抑制了基因素脱乙酶 (HDAC) 酶,并逆转了癌细胞中西斯普拉丁的耐药性. 这种新型HDAC抑制剂通过增强DNA损伤和亡,显示出对协同癌症治疗的前景.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 结构生物学 结构生物学
背景情况:
- 基斯脱乙酶 (HDAC) 抑制剂在癌症治疗中至关重要.
- 开发具有提高疗效和逆转耐药性质的新型HDAC抑制剂至关重要.
- 了解HDAC抑制剂的结合机制有助于药物设计.
研究的目的:
- 为了合成和评估新的基于peptoid的HDAC抑制剂.
- 为了研究合成化合物的抗等离子体活性和细胞毒性.
- 为了阐明化合物DS-103与HDAC6.6的结合方式.
主要方法:
- 合成具有多种链接区域和结合群的基于类化合物.
- 在体外测定HDAC抑制,抗等离子体活性和细胞毒性.
- 进行X射线晶体学以确定DS-103与HDAC6.6复合体中的结构.
主要成果:
- DS-103证明了强大的纳米分子抑制I类HDACs和HDAC6.
- 具有HDAC6的DS-103的晶体结构为其结合模式提供了洞察力.
- 在抗的癌症细胞系中,DS-103逆转了对的抗性,并与显示出协同作用.
- 协同效应涉及增加的DNA损伤,p21表达和卡斯巴酶介导的亡.
结论:
- DS-103是一种高效的基于peptoid的HDAC抑制剂,在癌症治疗中具有显著的潜力.
- DS-103克服了西斯普拉丁耐药性,并与西斯普拉丁表现出协同效应.
- DS-103-HDAC6复合物的结构洞察力可以指导HDAC抑制剂的未来药物开发.
相关概念视频
Diazonium Group Substitution: –OH and –H
2.7K
Nitrous acid, a weak acid, is prepared in situ via the reaction of sodium nitrite with a strong acid under cold conditions. This nitrous acid prepared in situ reacts with primary arylamines to form arenediazonium salts. Such reactions are known as diazotization reactions. As shown in Figure 1, the formation of arenediazonium salts begins with the decomposition of nitrous acid in an acidic solution to give nitrosonium ions.
2.7K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K

